Literature DB >> 30230041

Virtual reality exercise intradialysis to improve physical function: A feasibility randomized trial.

Eva Segura-Ortí1, Borja Pérez-Domínguez1, Lucía Ortega-Pérez de Villar1, Erika Meléndez-Oliva1, Javier Martínez-Gramage1, Rafael García-Maset2, José Antonio Gil-Gómez3.   

Abstract

OBJECTIVE: The main objective of this investigation was to assess feasibility of conducting a future RCT with an intradialysis non-immersive virtual reality exercise intervention. The secondary aim was to explore the impact of either conventional or VR exercise on physical function.
DESIGN: Feasibility randomized trial. PARTICIPANTS: Eighteen subjects who participated in a 16-week intradialysis combined exercise program.
INTERVENTIONS: The program lasted four additional weeks of either combined exercise or virtual reality exercise. MAIN OUTCOME MEASURES: Physical function was measured through several reliable tests (sit-to-stand-to-sit tests 10 and 60, gait speed, one-leg heel-rise tests, and 6-minute walk test) at baseline, after 16 weeks of intradialysis combined exercise and by the end of four additional weeks of exercise. Adherence to the exercise programs was registered.
RESULTS: There was a significant time effect, so that physical function improved in both groups. By the end of the 20 weeks, function improved as measured through the sit-to-stand-to-sit tests 10 and 60, gait speed, one-leg heel-rise left leg, and the 6-minute walk test. Changes that did not occur due to error in the test were seen after 20 weeks were achieved in the sit-to-stand-to-sit test 60, gait speed, one-leg heel-rise test for the left leg, and 6-minute walking test.
CONCLUSION: Virtual reality was a feasible intervention. Both interventions improved physical function. Adherence was not significantly different between groups.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adherence; exercise; hemodialysis; physical function; virtual reality

Mesh:

Year:  2018        PMID: 30230041     DOI: 10.1111/sms.13304

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  5 in total

1.  Impact of an intradialysis virtual-reality-based exercise program on healthcare resources expenditure: a micro-costing analysis.

Authors:  Alicia García-Testal; Francisco José Martínez-Olmos; Jose Antonio Gil-Gómez; Javier Villalón-Coca; Rafael Ortiz-Ramón; Alicia Cana-Poyatos; Rafael García-Maset; Eva Segura-Ortí
Journal:  BMC Nephrol       Date:  2022-06-27       Impact factor: 2.585

2.  Comparison of intradialytic versus home-based exercise programs on physical functioning, physical activity level, adherence, and health-related quality of life: pilot study.

Authors:  Lucía Ortega-Pérez de Villar; Francisco José Martínez-Olmos; Vicent Benavent-Caballer; Francisco Javier Montañez-Aguilera; Tom Mercer; Eva Segura-Ortí; Francisco de Borja Pérez-Domínguez
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

Review 3.  Non-Immersive Virtual Reality for Rehabilitation of the Older People: A Systematic Review into Efficacy and Effectiveness.

Authors:  Roberta Bevilacqua; Elvira Maranesi; Giovanni Renato Riccardi; Valentina Di Donna; Paolo Pelliccioni; Riccardo Luzi; Fabrizia Lattanzio; Giuseppe Pelliccioni
Journal:  J Clin Med       Date:  2019-11-05       Impact factor: 4.241

4.  Intradialytic Cardiovascular Exercise Training Alters Redox Status, Reduces Inflammation and Improves Physical Performance in Patients with Chronic Kidney Disease.

Authors:  Apostolos Sovatzidis; Athanasios Chatzinikolaou; Ioannis G Fatouros; Stylianos Panagoutsos; Dimitrios Draganidis; Eirini Nikolaidou; Alexandra Avloniti; Yiannis Michailidis; Ioannis Mantzouridis; Alexios Batrakoulis; Ploumis Pasadakis; Vassilis Vargemezis
Journal:  Antioxidants (Basel)       Date:  2020-09-15

5.  Virtual reality reduces pain in palliative care-A feasibility trial.

Authors:  Miriam Guenther; Dennis Görlich; Florian Bernhardt; Esther Pogatzki-Zahn; Burkhard Dasch; Janina Krueger; Philipp Lenz
Journal:  BMC Palliat Care       Date:  2022-10-05       Impact factor: 3.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.